Does Biology Transcend the Symptom-based Boundaries of Psychosis?

Godfrey D. Pearlson; Brett A. Clementz; John A. Sweeney; Matcheri S. Keshavan; Carol A. Tamminga

doi:10.1016/j.psc.2016.01.001

Does Biology Transcend the Symptom-based Boundaries of Psychosis?

Godfrey D. Pearlson, Brett A. Clementz, John A. Sweeney, Matcheri S. Keshavan, Carol A. Tamminga

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	165-174
Number of pages	10
Journal	Psychiatric Clinics of North America
Volume	39
Issue number	2
DOIs	https://doi.org/10.1016/j.psc.2016.01.001
State	Published - Jun 1 2016

Keywords

Biotype
Bipolar
Neurobiology
Psychosis
Reclassification
Schizoaffective
Schizophrenia

ASJC Scopus subject areas

Psychiatry and Mental health

Access to Document

10.1016/j.psc.2016.01.001

Cite this

@article{f7a773f4007e4abbb7692b3d0a076b52,

title = "Does Biology Transcend the Symptom-based Boundaries of Psychosis?",

keywords = "Biotype, Bipolar, Neurobiology, Psychosis, Reclassification, Schizoaffective, Schizophrenia",

author = "Pearlson, {Godfrey D.} and Clementz, {Brett A.} and Sweeney, {John A.} and Keshavan, {Matcheri S.} and Tamminga, {Carol A.}",

note = "Funding Information: Potential Conflicts of Interest: Dr J.A. Sweeney has received support from Takeda , BMS , Lilly , Roche , and Janssen . Dr M.S. Keshavan has received support from Sunovion . Dr C.A. Tamminga has received funding from Astellas, Eli Lilly , Intracellular Therapies , Lundback , and Pure Tech Ventures . Other authors declare no financial interest in relation to the work described in this article other than National Institutes of Health grant funding. ",

year = "2016",

month = jun,

day = "1",

doi = "10.1016/j.psc.2016.01.001",

language = "English (US)",

volume = "39",

pages = "165--174",

journal = "Psychiatric Clinics of North America",

issn = "0193-953X",